Cargando…

Deep Learning With 18F-Fluorodeoxyglucose-PET Gives Valid Diagnoses for the Uncertain Cases in Memory Impairment of Alzheimer’s Disease

Objectives: Neuropsychological tests are an important basis for the memory impairment diagnosis in Alzheimer’s disease (AD). However, multiple memory tests might be conflicting within-subjects and lead to uncertain diagnoses in some cases. This study proposed a framework to diagnose the uncertain ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Zhang, Tianhao, Pan, Tingting, Zhao, Shilun, Nie, Binbin, Liu, Hua, Shan, Baoci
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715958/
https://www.ncbi.nlm.nih.gov/pubmed/34975455
http://dx.doi.org/10.3389/fnagi.2021.764272
_version_ 1784624226729197568
author Zhang, Wei
Zhang, Tianhao
Pan, Tingting
Zhao, Shilun
Nie, Binbin
Liu, Hua
Shan, Baoci
author_facet Zhang, Wei
Zhang, Tianhao
Pan, Tingting
Zhao, Shilun
Nie, Binbin
Liu, Hua
Shan, Baoci
author_sort Zhang, Wei
collection PubMed
description Objectives: Neuropsychological tests are an important basis for the memory impairment diagnosis in Alzheimer’s disease (AD). However, multiple memory tests might be conflicting within-subjects and lead to uncertain diagnoses in some cases. This study proposed a framework to diagnose the uncertain cases of memory impairment. Methods: We collected 2,386 samples including AD, mild cognitive impairment (MCI), and cognitive normal (CN) using 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) and three different neuropsychological tests (Mini-Mental State Examination, Alzheimer’s Disease Assessment Scale-Cognitive Subscale, and Clinical Dementia Rating) from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). A deep learning (DL) framework using FDG-PET was proposed to diagnose uncertain memory impairment cases that were conflicting between tests. Subsequent ANOVA, chi-squared, and t-test were used to explain the potential causes of uncertain cases. Results: For certain cases in the testing set, the proposed DL framework outperformed other methods with 95.65% accuracy. For the uncertain cases, its positive diagnoses had a significant (p < 0.001) worse decline in memory function than negative diagnoses in a longitudinal study of 40 months on average. In the memory-impaired group, uncertain cases were mainly explained by an AD metabolism pattern but mild in extent (p < 0.05). In the healthy group, uncertain cases were mainly explained by a non-energetic mental state (p < 0.001) measured using a global deterioration scale (GDS), with a significant depression-related metabolism pattern detected (p < 0.05). Conclusion: A DL framework for diagnosing uncertain cases of memory impairment is proposed. Proved by longitudinal tracing of its diagnoses, it showed clinical validity and had application potential. Its valid diagnoses also provided evidence and explanation of uncertain cases based on the neurodegeneration and depression mental state.
format Online
Article
Text
id pubmed-8715958
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87159582021-12-30 Deep Learning With 18F-Fluorodeoxyglucose-PET Gives Valid Diagnoses for the Uncertain Cases in Memory Impairment of Alzheimer’s Disease Zhang, Wei Zhang, Tianhao Pan, Tingting Zhao, Shilun Nie, Binbin Liu, Hua Shan, Baoci Front Aging Neurosci Neuroscience Objectives: Neuropsychological tests are an important basis for the memory impairment diagnosis in Alzheimer’s disease (AD). However, multiple memory tests might be conflicting within-subjects and lead to uncertain diagnoses in some cases. This study proposed a framework to diagnose the uncertain cases of memory impairment. Methods: We collected 2,386 samples including AD, mild cognitive impairment (MCI), and cognitive normal (CN) using 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) and three different neuropsychological tests (Mini-Mental State Examination, Alzheimer’s Disease Assessment Scale-Cognitive Subscale, and Clinical Dementia Rating) from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). A deep learning (DL) framework using FDG-PET was proposed to diagnose uncertain memory impairment cases that were conflicting between tests. Subsequent ANOVA, chi-squared, and t-test were used to explain the potential causes of uncertain cases. Results: For certain cases in the testing set, the proposed DL framework outperformed other methods with 95.65% accuracy. For the uncertain cases, its positive diagnoses had a significant (p < 0.001) worse decline in memory function than negative diagnoses in a longitudinal study of 40 months on average. In the memory-impaired group, uncertain cases were mainly explained by an AD metabolism pattern but mild in extent (p < 0.05). In the healthy group, uncertain cases were mainly explained by a non-energetic mental state (p < 0.001) measured using a global deterioration scale (GDS), with a significant depression-related metabolism pattern detected (p < 0.05). Conclusion: A DL framework for diagnosing uncertain cases of memory impairment is proposed. Proved by longitudinal tracing of its diagnoses, it showed clinical validity and had application potential. Its valid diagnoses also provided evidence and explanation of uncertain cases based on the neurodegeneration and depression mental state. Frontiers Media S.A. 2021-12-15 /pmc/articles/PMC8715958/ /pubmed/34975455 http://dx.doi.org/10.3389/fnagi.2021.764272 Text en Copyright © 2021 Zhang, Zhang, Pan, Zhao, Nie, Liu, Shan and Alzheimer’s Disease Neuroimaging Initiative. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Zhang, Wei
Zhang, Tianhao
Pan, Tingting
Zhao, Shilun
Nie, Binbin
Liu, Hua
Shan, Baoci
Deep Learning With 18F-Fluorodeoxyglucose-PET Gives Valid Diagnoses for the Uncertain Cases in Memory Impairment of Alzheimer’s Disease
title Deep Learning With 18F-Fluorodeoxyglucose-PET Gives Valid Diagnoses for the Uncertain Cases in Memory Impairment of Alzheimer’s Disease
title_full Deep Learning With 18F-Fluorodeoxyglucose-PET Gives Valid Diagnoses for the Uncertain Cases in Memory Impairment of Alzheimer’s Disease
title_fullStr Deep Learning With 18F-Fluorodeoxyglucose-PET Gives Valid Diagnoses for the Uncertain Cases in Memory Impairment of Alzheimer’s Disease
title_full_unstemmed Deep Learning With 18F-Fluorodeoxyglucose-PET Gives Valid Diagnoses for the Uncertain Cases in Memory Impairment of Alzheimer’s Disease
title_short Deep Learning With 18F-Fluorodeoxyglucose-PET Gives Valid Diagnoses for the Uncertain Cases in Memory Impairment of Alzheimer’s Disease
title_sort deep learning with 18f-fluorodeoxyglucose-pet gives valid diagnoses for the uncertain cases in memory impairment of alzheimer’s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715958/
https://www.ncbi.nlm.nih.gov/pubmed/34975455
http://dx.doi.org/10.3389/fnagi.2021.764272
work_keys_str_mv AT zhangwei deeplearningwith18ffluorodeoxyglucosepetgivesvaliddiagnosesfortheuncertaincasesinmemoryimpairmentofalzheimersdisease
AT zhangtianhao deeplearningwith18ffluorodeoxyglucosepetgivesvaliddiagnosesfortheuncertaincasesinmemoryimpairmentofalzheimersdisease
AT pantingting deeplearningwith18ffluorodeoxyglucosepetgivesvaliddiagnosesfortheuncertaincasesinmemoryimpairmentofalzheimersdisease
AT zhaoshilun deeplearningwith18ffluorodeoxyglucosepetgivesvaliddiagnosesfortheuncertaincasesinmemoryimpairmentofalzheimersdisease
AT niebinbin deeplearningwith18ffluorodeoxyglucosepetgivesvaliddiagnosesfortheuncertaincasesinmemoryimpairmentofalzheimersdisease
AT liuhua deeplearningwith18ffluorodeoxyglucosepetgivesvaliddiagnosesfortheuncertaincasesinmemoryimpairmentofalzheimersdisease
AT shanbaoci deeplearningwith18ffluorodeoxyglucosepetgivesvaliddiagnosesfortheuncertaincasesinmemoryimpairmentofalzheimersdisease
AT deeplearningwith18ffluorodeoxyglucosepetgivesvaliddiagnosesfortheuncertaincasesinmemoryimpairmentofalzheimersdisease